Optimisation of an Electrochemical DNA Sensor for Measuring KRAS G12D and G13D Point Mutations in Different Tumour Types
Circulating tumour DNA (ctDNA) is widely used in liquid biopsies due to having a presence in the blood that is typically in proportion to the stage of the cancer and because it may present a quick and practical method of capturing tumour heterogeneity. This paper outlines a simple electrochemical te...
Main Authors: | Bukola Attoye, Matthew J. Baker, Fiona Thomson, Chantevy Pou, Damion K. Corrigan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Biosensors |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6374/11/2/42 |
Similar Items
-
Developing a Low-Cost, Simple-to-Use Electrochemical Sensor for the Detection of Circulating Tumour DNA in Human Fluids
by: Bukola Attoye, et al.
Published: (2020-10-01) -
KRAS G12D targeted therapies for pancreatic cancer: Has the fortress been conquered?
by: Sahar F. Bannoura, et al.
Published: (2022-11-01) -
Structural dataset for the fast-exchanging KRAS G13D
by: Jia Lu, et al.
Published: (2015-12-01) -
Targeting <i>KRAS</i> G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver
by: Javier Ros, et al.
Published: (2024-03-01) -
KrasG12D induces changes in chromatin territories that differentially impact early nuclear reprogramming in pancreatic cells
by: Angela J. Mathison, et al.
Published: (2021-10-01)